The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients

@inproceedings{Colombo2017TheGA,
  title={The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients},
  author={Delia Maria Colombo and Giuseppe Banfi and Nicoletta Cassano and Alessandra Graziottin and Gino Antonio Vena and Giovanni Gualberto Fiori and Emanuela Zagni and Luca Stingeni and Sergio Chimenti and Enzo Berardesca and Giuseppe Micali and Giuseppe Albertini and Clara De simone and Gilberto Bellia and Salvatore Amato and Fabio Ayala and Ferderico Bardazzi and Maria Grazia Bernengo and Maria Rita Bongiorno and Giovanni Borroni and Stefano S Calvieri and Piergiacomo Calzavara Pinton and Calcedonio Cannarozzo and Serafinella Patrizia Cannav{\`o} and Angelo D. Cattaneo and Rossella Ceschini and Enrico Colombo and Maurizio Congedo and Francesco Cusano and Ornella de Pit{\`a} and Sergio di Nuzzo and Dario Donadio and Stefano Donelli and Raffaele Filotico and Maria Laura Flori and M. Germino and Giampiero Girolomoni and Franco Kokelj and Anna Lanzoni and Giuseppe Lembo and Andrea Locatelli and Cristina Magnoni and Marco Marconi and Alberico Motolese and Manuela Papini and Aurora Parodi and M. Ram{\'i}rez-de Santa Pau and Ketty Peris and S. Piaserico and Angelo Piccirillo and Concetta Potenza and Giuseppe Ricotti and Patrizio Sedona and Giuseppe Stinco and Giancarlo Valenti and Cleto Veller Fornasa and Leonardo Zichichi and Alessandra Ori and Christian Amici and Alessandro Zullo and Lucia Simoni and Nicole Lanci and Chiara Longagnani and Saide Sala and Francesca Trevisan and Giovanna Magri},
  booktitle={Advances in therapy},
  year={2017}
}
INTRODUCTION Female sex has been shown to be a risk factor for the development of adverse drug reactions; however, this has not been studied for cyclosporine (CsA). The aim of this study was to investigate, in Italian dermatological practice, the influence of gender and menopause and related hormones on the incidence of adverse events (AEs) during CsA… CONTINUE READING